Brand-name · GLP-1 receptor agonist (semaglutide)

Wegovy® Pens

Wegovy® once-weekly injection for chronic weight management in adults with obesity with a weight-related condition, and to reduce the risk of major cardiovascular events.

Starting at$349.99/mo

Check If I Qualify Read the FAQs

Form

Pre-filled injection pen

Frequency

Once weekly

Drug class

GLP-1 receptor agonist (semaglutide)

Who is a candidate for this medication?

Adults 18+ with BMI 30+, or 27+ with a weight-related condition.
Established cardiovascular disease and elevated cardiac risk (per label).

Who this medication is not for

Personal or family history of medullary thyroid cancer or MEN 2.
Pregnancy, planning pregnancy, or breastfeeding.
History of pancreatitis.

Dosage overview

Phase	Dose
Weeks 1–4	0.25 mg once weekly.
Titration	Increased every 4 weeks to a maintenance dose of 2.4 mg.

Side effects to know about

Common

· Nausea
· Diarrhea
· Vomiting
· Constipation

Serious (call your doctor)

· Pancreatitis
· Gallbladder disease
· Kidney injury
· Diabetic retinopathy complications in type 2 diabetes

How your care is monitored

Monthly during titration, quarterly at maintenance.
Cardiovascular symptom review if indicated.

Pricing

Wegovy® Pens starts at $349.99/mo. No insurance required. HSA/FSA eligible. Cancel anytime.

Common questions

Is Wegovy the same as Ozempic?

Same active ingredient (semaglutide). Wegovy is approved for weight management; Ozempic is approved for type 2 diabetes. Doses and pens differ.

Ready to see if Wegovy is right for you?

Complete a 5-minute online intake. A US-licensed physician reviews your history and only prescribes if it's safe and appropriate for you.

Check If I Qualify — Free & Fast

Compare other medications

Compounded

Compounded Semaglutide

From $149.99/28-day supply

Compounded

Compounded Tirzepatide

From $249.99/28-day supply